214 related articles for article (PubMed ID: 1650830)
1. Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
France CP; Winger G; Medzihradsky F; Seggel MR; Rice KC; Woods JH
J Pharmacol Exp Ther; 1991 Aug; 258(2):502-10. PubMed ID: 1650830
[TBL] [Abstract][Full Text] [Related]
2. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.
France CP; Gerak LR; Flynn D; Winger GD; Medzihradsky F; Bagley JR; Brockunier LL; Woods JH
J Pharmacol Exp Ther; 1995 Jul; 274(1):17-28. PubMed ID: 7616395
[TBL] [Abstract][Full Text] [Related]
3. Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities.
France CP; Medzihradsky F; Woods JH
J Pharmacol Exp Ther; 1994 Jan; 268(1):47-58. PubMed ID: 8301589
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of a deuterium-substituted mirfentanil derivative, OHM10579, in rhesus monkeys.
Lelas S; Gerak LR; Landers LK; Brandt MR; Bagley JR; Brockunier LL; France CP
Pharmacol Biochem Behav; 1998 Jul; 60(3):665-75. PubMed ID: 9678650
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys.
France CP; Winger G; Seggel MR; Rice KC; Woods JH
Psychopharmacology (Berl); 1992; 109(3):291-8. PubMed ID: 1365629
[TBL] [Abstract][Full Text] [Related]
6. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
Negus SS; Burke TF; Medzihradsky F; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
France CP; Woods JH
J Pharmacol Exp Ther; 1989 Sep; 250(3):937-43. PubMed ID: 2550623
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
11. Mirfentanil antagonizes morphine-induced suppression of splenic NK activity in mice.
Carr DJ; Brockunier LL; Scott M; Bagley JR; France CP
Immunopharmacology; 1996 Aug; 34(1):9-16. PubMed ID: 8880221
[TBL] [Abstract][Full Text] [Related]
12. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
Bertalmio AJ; Woods JH
J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
[TBL] [Abstract][Full Text] [Related]
13. Morphine, saline and naltrexone discrimination in morphine-treated pigeons.
France CP; Woods JH
J Pharmacol Exp Ther; 1987 Jul; 242(1):195-202. PubMed ID: 3612524
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
France CP; Gerak LR
J Pharmacol Exp Ther; 1994 Sep; 270(3):992-9. PubMed ID: 7932212
[TBL] [Abstract][Full Text] [Related]
15. Effects of a novel fentanyl derivative on drug discrimination and learning in rhesus monkeys.
Gerak LR; Moerschbaecher JM; Bagley JR; Brockunier LL; France CP
Pharmacol Biochem Behav; 1999 Oct; 64(2):367-71. PubMed ID: 10515315
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons.
France CP; Woods JH
J Pharmacol Exp Ther; 1990 Aug; 254(2):626-32. PubMed ID: 2384889
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
Gerak LR; Butelman ER; Woods JH; France CP
J Pharmacol Exp Ther; 1994 Nov; 271(2):993-9. PubMed ID: 7965822
[TBL] [Abstract][Full Text] [Related]
18. Naloxone benzylhydrazone is a ยต-selective opioid antagonist without kappa agonist effects in rhesus monkeys.
France CP; Woods JH
Behav Pharmacol; 1992 Apr; 3(2):133-141. PubMed ID: 11224111
[TBL] [Abstract][Full Text] [Related]
19. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
Sell SL; McMahon LR; France CP
J Pharmacol Exp Ther; 2003 Sep; 306(3):1167-73. PubMed ID: 12766254
[TBL] [Abstract][Full Text] [Related]
20. Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone.
France CP; de Costa BR; Jacobson AE; Rice KC; Woods JH
J Pharmacol Exp Ther; 1990 Feb; 252(2):600-4. PubMed ID: 2156055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
